comparemela.com

Latest Breaking News On - Soleno therapeutics inc - Page 6 : comparemela.com

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Soleno therapeutics incBrian ritchielifesci advisorsNasdaq stock marketNasdaq listing ruleEquity incentive planSoleno therapeuticsInc solenoDiazoxide choline

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Brian ritchieSoleno therapeutics incLifesci advisorsNasdaq stock marketNasdaq listing ruleEquity incentive planSoleno therapeuticsDiazoxide cholineSci advisors

Soleno Therapeutics, Inc (NASDAQ:SLNO) CEO Sells $784,633 20 in Stock

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […]

Stifel nicolausBhatnagar anishPiper sandlerSilverarc capital managementSecurities exchange commissionSchonfeld strategic advisorsEmerald mutual fund advisersWalleye capitalSoleno therapeutics incCarlyle group incSoleno therapeuticsGet free reportExchange commissionStrategic advisorsMutual fund advisers trustDiazoxide choline extended release

Soleno Therapeutics, Inc (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 Shares

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […]

Stifel nicolausPiper sandlerCarlyle group incSoleno therapeutics incNantahala capital managementVivo capitalWorth venture partnersPerceptive advisorsSoleno therapeutics company profileSoleno therapeuticsGet free reportKristen yenCapital managementDiazoxide choline extended releaseSoleno therapeutics dailyNasdaq slno

Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (NASDAQ:SLNO), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Soleno therapeutics incChief financial officer

vimarsana © 2020. All Rights Reserved.